Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_3
1
7%
Ph not_applicable
5
36%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Completed(8)
Terminated(1)
Other(5)

Detailed Status

Completed8
unknown5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
88.9%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (16.7%)
N/A5 (83.3%)

Trials by Status

completed857%
terminated17%
unknown536%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
PROCEDURE
Total Trials
14